ALEX SALA: Open Payments
NPI 1376242420 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,977 in 184 payments from 19 companies in 2025. Trend: 2023 $329 · 2024 $1,364 · 2025 $3,977
Food & beverage: $3,977
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 64 | $1,412 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $486 |
| Aimmune Therapeutics, Inc. | 10 | $202 |
| Ardelyx, Inc. | 11 | $197 |
| Lilly USA, LLC | 10 | $193 |
| Janssen Biotech, Inc. | 15 | $191 |
| GENZYME CORPORATION | 6 | $185 |
| Ipsen Biopharmaceuticals, Inc | 7 | $184 |
| EVOKE PHARMA, INC. | 4 | $153 |
| Madrigal Pharmaceuticals | 8 | $152 |
Products named: RINVOQ, DUPIXENT, LINZESS, CREON, ENTYVIO, IBSRELA, OMVOH, TREMFYA.
Industry payments across TX — which companies pay providers there.
